Ad5-trail - an adenovirus type 5 (ad5) encoding human tumor necrosis factor-related apoptosis-inducing ligand (trail), with potential apoptosis-inducing and antineoplastic activities. Upon administration of recombinant ad5 encoding trail, the adenovirus selectively infects tumor cells and expresses trail. The virally expressed trail binds to and activates its receptors trail receptor-1 (trail-r1, death receptor 4, dr4) and trail receptor-2 (trail-r2, death receptor 5, dr5), which subsequently activate caspases and induce apoptosis in trail-r1/r2-expressing tumor cells. The pro-apoptotic cell surface receptors trail-r1 and -r2, members of the tnf receptor family, are overexpressed by a variety of cancer cell types. Also see recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand
Up to date info
Latest research - Ad5-trail
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Ad5-trail for any updates.